What Researchers Did
Researchers assessed whether volatile organic compounds (VOCs) in exhaled breath are early markers of hyperoxic stress or pulmonary oxygen toxicity (POT) following COMEX-30 hyperbaric treatment in ten healthy volunteers.
What They Found
Nine VOCs were identified, with four compounds (nonanal, decanal, ethyl acetate, and tridecane) increasing 33-500% in intensity after COMEX-30 treatment. Seven out of ten subjects reported transient pulmonary symptoms, leading researchers to conclude that the identified VOCs are likely markers of early-stage POT.
What This Means for Canadian Patients
This research suggests that specific volatile organic compounds in exhaled breath could serve as early indicators of pulmonary oxygen toxicity in divers undergoing hyperbaric treatment. This non-invasive method may allow for earlier intervention and improved management of potential complications from decompression sickness therapy.
Canadian Relevance
There is no direct Canadian connection mentioned in this study.
Study Limitations
The study was conducted with a small sample size of ten healthy volunteers, which may limit the generalizability of the findings.